Към основното съдържание

Преглед

CME Group Inc. Financial Statements FY2024-FY2026Q3

CME's income statement and balance sheet, FY2024 through FY2026Q3, as a public, auditable plain-text Beancount ledger — reconstructed line by line from the company's own Form 10-K and 10-Q filings and version-controlled in git. Part of t… Бележки към книгата

Финансова позиция

Нетна стойност и сметките, които я формират

Нетна стойност
Активи плюс пасиви през последните 12 месеца
26 560,3 MUSD
-2167,9 MUSDспрямо предходния месец
Сметки
Текущи салда по сметки за активи и пасиви

Движение на средства

Месечни приходи и разходи по категория сметки

септември 2026 г.
Входящи средства
септември 2026 г.
+3258,2 MUSD
Водещи източници
Средно за до 3 предходни периода
—
Виж всички
Изходящи средства
септември 2026 г.
-2221,3 MUSD
Най-големи разходи
Средно за до 3 предходни периода
—
Виж всички

Скорошна активност

Активност от журнала с отчитане на осчетоводяванията

Транзакции
Най-новите транзакции според текущите филтри

Доходи срещу разходи

Доходи срещу разходи
Стълбовидна диаграма, сравняваща общите доходи и разходи за всеки интервал в избрания период.
Данни по периоди
ПериодДоходиРазходиНетна печалба
2024-12-3110 560,1 MUSD7034,3 MUSD3525,8 MUSD
2025-01-310 MUSD0 MUSD0 MUSD
2025-02-280 MUSD0 MUSD0 MUSD
2025-03-310 MUSD0 MUSD0 MUSD
2025-04-300 MUSD0 MUSD0 MUSD
2025-05-310 MUSD0 MUSD0 MUSD
2025-06-300 MUSD0 MUSD0 MUSD
2025-07-310 MUSD0 MUSD0 MUSD
2025-08-310 MUSD0 MUSD0 MUSD
2025-09-300 MUSD0 MUSD0 MUSD
2025-10-310 MUSD0 MUSD0 MUSD
2025-11-300 MUSD0 MUSD0 MUSD
2025-12-3112 628,8 MUSD8556,6 MUSD4072,2 MUSD
2026-01-310 MUSD0 MUSD0 MUSD
2026-02-280 MUSD0 MUSD0 MUSD
2026-03-310 MUSD0 MUSD0 MUSD
2026-04-300 MUSD0 MUSD0 MUSD
2026-05-310 MUSD0 MUSD0 MUSD
2026-06-300 MUSD0 MUSD0 MUSD
2026-07-310 MUSD0 MUSD0 MUSD
2026-08-310 MUSD0 MUSD0 MUSD
2026-09-303258,2 MUSD2221,3 MUSD1036,9 MUSD

Баланс

Разпределение на активи
Визуално представяне на състава на CME Group Inc. Financial Statements FY2024-FY2026Q3 активи
Разбивка
СметкаСумаДял от общата сума
Assets:NonCurrent:TradingProducts17 175,3 MUSD8,94%
Assets:NonCurrent:Other2494,3 MUSD1,3%
Assets:NonCurrent:IntangibleAssets2440,1 MUSD1,27%
Assets:NonCurrent:Goodwill10 505,9 MUSD5,47%
Assets:Current:PerformanceBonds155 179,7 MUSD80,78%
Assets:Current:Cash2198,5 MUSD1,14%
Други2098,7 MUSD1,09%
Разпределение на пасиви
Визуално представяне на състава на CME Group Inc. Financial Statements FY2024-FY2026Q3 пасиви
Разбивка
СметкаСумаДял от общата сума
Liabilities:NonCurrent:Other5994,2 MUSD3,62%
Liabilities:NonCurrent:LongTermDebt3425,1 MUSD2,07%
Liabilities:Current:PerformanceBonds155 179,7 MUSD93,75%
Други933,2 MUSD0,56%

Паричен поток

Паричен поток
Парично движение от източници на доходи към разходи и инвестиции

Зареждане на ролите на сметките…

README.md

CME Group Inc. (CME) Financial Statements in Beancount — Open Ledger

CME's income statement and balance sheet, FY2024 through FY2026Q3, as a public, auditable plain-text Beancount ledger — reconstructed line by line from the company's own Form 10-K and 10-Q filings and version-controlled in git. Part of the Open Ledger project on beancount.io.

Browse it live: beancount.io/ledger/open_ledger/cme-group

Latest analysis: CME Group Q3 2026 Earnings: Record $1.74B Revenue on 29.4M Contracts a Day

Key Figures

PeriodPeriod endRevenueNet income
FY20242024-12-316,130.13,525.8
FY20252025-12-316,520.64,072.2
FY2026Q32026-09-301,737.31,036.9

Amounts in MUSD (millions of US dollars), exactly as the ledger records them.

What's Inside

Fiscal years end December 31. All figures sourced from CME Group Inc. Form 10-K and Form 10-Q filings (SEC EDGAR, CIK 0001156375).

Quick Start

bash
uvx --from beancount bean-check main.bean
uvx --from beanquery bean-query main.bean \
  "SELECT year, sum(position) WHERE account ~ '^Income:Revenue' GROUP BY year ORDER BY year"

Zero output from bean-check means the ledger is internally consistent: every
income statement sums to zero and every balance-sheet snapshot reconciles to
the filed totals. The query prints revenue by calendar year; income is a
credit, so it shows as a negative number. Open main.bean in Fava
or import it into beancount.io to explore it visually.

Methodology

  • Balance sheet — pad / balance directives assert each period-end
    figure against the filing named in that period file's source banner.
  • Income statement — one zero-sum transaction per period: Income
    negative (credit), Expenses positive (debit), with the arithmetic check in
    a comment directly above it.
  • Unit — MUSD; 1,737.3 MUSD means 1,737.3 million US dollars.
  • Clearing collateral, gross — performance bonds and guaranty fund
    contributions sit on both sides in equal amounts and are never netted;
    Assets:NonCurrent:TradingProducts holds the indefinite-lived product
    intangibles apart from the amortizing ones.
  • Additional accounts — Assets:Current:PerformanceBonds,
    Assets:NonCurrent:TradingProducts, Liabilities:Current:PerformanceBonds,
    Expenses:CompensationAndBenefits, Expenses:OperatingExpenses,
    Expenses:AmortizationOfAcquiredIntangibles,
    Expenses:DepreciationAndAmortization, Expenses:Interest, opened beyond the
    standard chart (see each account's open line in main.bean).

Analysis

Corrections

Found a figure that does not match the filing? Email
[email protected] with the period, the account
and the filing page. Corrections are committed with the source cited.

About Open Ledger

Open Ledger is a growing library of public-company financial statements
published as plain-text accounting at
beancount.io/ledger — git-versioned, diffable
across companies, and auditable against primary filings. Read the analysis
behind the numbers on the beancount.io blog.

Disclaimer

This ledger is an independent reconstruction of CME Group Inc.'s publicly filed
financial statements, provided for educational and informational purposes
only. It is not investment, financial, legal, tax, or accounting advice, and
is not an offer or recommendation to buy or sell any security. Beancount.io is
not affiliated with, endorsed by, or sponsored by CME Group Inc.; all trademarks
belong to their respective owners. Figures may contain errors, omissions, or
simplifications and may lag the latest filings — the company's own regulatory
filings are the authoritative source. Provided "as is" without warranty of any
kind; use at your own risk.